Scipher Medicine Revenue and Competitors

Boston, MA USA

Location

$227M

Total Funding

Biotech

Industry

Estimated Revenue & Valuation

  • Scipher Medicine's estimated annual revenue is currently $28.7M per year.(i)
  • Scipher Medicine's estimated revenue per employee is $193,750
  • Scipher Medicine's total funding is $227M.

Employee Data

  • Scipher Medicine has 148 Employees.(i)
  • Scipher Medicine grew their employee count by -10% last year.
Competitor NameRevenueNumber of EmployeesEmployee GrowthTotal FundingValuation
#1
$5.2M67-45%$107.3MN/A
#2
$0.2M10%N/AN/A
#3
$4.2M2735%N/AN/A
#4
$11.9M77-37%$312.8MN/A
#5
$1.4M929%N/AN/A
#6
$235M255-31%$340.9MN/A
#7
$45.9M237-7%$7.6MN/A
#8
$3.9M5035%N/AN/A
#9
$5.3M340%N/AN/A
#10
$1.9M12-8%N/AN/A
Add Company

Scipher Medicine is building the future of patient treatment. Most patients who are prescribed blockbuster therapies today donᅢᄁ¬ツᆲ¬トᄁt respond to the treatment, costing the health care industry billions in wasted drugs while patients continue to suffer. Scipher's platform identifies which drug will work based on the patient's fundamental disease biology, and not based on symptoms, disease classification, or medical bias. A simple test predicts which drug he/she will respond to, ensuring that most optimal treatment is prescribed from day one. The molecular data generated by our tests is then used to fuel novel target discovery to address a clear unmet medical need in patients who do not respond to any existing therapy.

keywords:N/A

$227M

Total Funding

148

Number of Employees

$28.7M

Revenue (est)

-10%

Employee Growth %

N/A

Valuation

N/A

Accelerator

Scipher Medicine News

2022-04-20 - How Businesses Are Solving America's Healthcare Problems

Scipher Medicine is a precision immunology company that helps match ... novel drugs with the same technology is an amazing development,...

2022-03-30 - North America's medical devices industry saw a drop of 2.78 ...

North America's medical devices industry saw a drop of 2.78% in deal ... Optum Ventures $110m venture financing deal with Scipher Medicine...

2021-03-25 - Scipher Medicine Raises $82M in Series C Funding

Scipher Medicine, a Waltham, Mass.-based precision immunology company matching patients with the most effective therapy, completed an $82m Series C financing. The round was led by aMoon and Northpond Ventures, with participation from Echo Health Ventures and existing investors, Khosla Ventures ...

2019-12-19 - Scipher Medicine Completes Series B Funding

Scipher Medicine, a Waltham, Mass.-based developer of a molecular technology platform used to ensure patients are prescribed the most effective therapy, closed a Series B financing. The amount of the deal was not discloseds. The round was led by Northpond Ventures, with participation from Alum ...

2018-09-10 - Scipher Medicine Completes Series A Funding

Scipher Medicine, a Waltham, MA-based developer of a molecular technology platform that can predict if a patient will actually respond to a particular drug therapy, completed its Series A funding round. The round, led by Khosla Ventures, brought total funds raised by the company to date to $10m ...

Company NameRevenueNumber of EmployeesEmployee GrowthTotal Funding
#1
$28.9M14918%$125.4M
#2
$34.4M149-6%N/A
#3
$41.1M14931%N/A
#4
$33.8M150-9%N/A
#5
$24.1M1511%N/A